We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
LSE:0A3S
​
​
logo

Novavax (0A3S)

LSE • 0A3S • US6700024010

10.65Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 14.9% of free float sold short, 139.5 days to cover, cost to borrow 0.69%. Sign up for live short interest data.

Market Cap

1.78b USD | # 1843 in GB

Volume

114.51k shares | 66.26m USD

Shares Outstanding

164.95m

Free Float Shares

88.64% | 146.21m

Nasdaq:NVAX|
DB:NVV1|
XTRA:NVV1|
SWX:NVAX|
WBAG:NVAX

News

0A3S key data

Novavax (LSE: 0A3S) has a market capitalization of $1.78B. Last close $10.65 (as of 2026-11-09); 52-week range $6.16 to $13.33. ORTEX data as of 2026-10-22: short interest was 14.87% of free float, 139.5 days to cover and the average cost to borrow was 0.69%. Sign up for live short interest data.

  • 0A3S news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.